EPAD publishes its LCS study protocol

  The EPAD project aims to develop an environment for and then test multiple different interventions targeting the secondary prevention of Alzheimer’s disease dementia. EPAD is conducting a Longitudinal Cohort Study (LCS) in alignment with a Bayesian adaptive designed EPAD Proof-of-Concept (PoC) trial. On 27 December 2018, an article presenting the EPAD LCS study protocol…

EPAD welcomes new partner MSD

We are pleased to announce the arrival of a new project partner, MSD (Merck Sharp and Dohme). We say a warm welcome to MSD and look forward to our collaboration. EPAD combines knowledge and expertise from 39 European organisations across multiple sectors, bringing a wealth of experience to our activities. The list of our partners…

Spotlight on Brescia

The EPAD family of trial delivery centres grew to 20 sites in August 2018 with Brescia (Italy) enrolling its first research participant. The team of Dr. Samantha Galluzzi (principal investigator of the EPAD project in Brescia) has currently recruited 15 participants in the EPAD Longitudinal Cohort Study (LCS). We caught up with the Brescia team…

Aridhia announces its partnership with Microsoft Azure

On 4 December, our partner Aridhia announced that its digital research platform AnalytiXagility used in the health, biomedical research and precision medicine sectors, is to move all its work to Azure, including treatment studies by the European Prevention of Alzheimer’s Dementia Consortium (EPAD). Aridhia will use Microsoft’s service to offer medical experts, such as those at EPAD,…

Spotlight on Tayside

This month, we get to know the Tayside centre behind EPAD. The site began recruiting in February 2018, with its first participant enrolled on 22nd February. The team has currently recruited 50 participants and still has 6 participants due in for baselines this month, taking the total to 56 participants by the end of November.…

Interview with Andy Bolan

What is your current role in EPAD? I am a brand-new member of the EPAD work package six. Having joined the Alzheimer’s team at Biogen in May 2018, the EPAD work was highlighted as a key coalition to join and support from a communications and advocacy perspective. I bring to the team over six years…

Interview with Kristy Draper

What is your current role in EPAD? I am the Global Trial Lead for the Proof of Concept Trial working in the Chief Investigator’s office at the University of Edinburgh.  In this role I am responsible for bringing together the EPAD team at the University and IQVIA to work with intervention owners who wish to…

The EPAD project publishes two new articles

In October 2018, two articles about the EPAD project were published. On 29 October, the journal Dementia published an article entitled “Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes”. The article led by Sarah Gregory from the University of Edinburgh (UK) described how the PREVENT Dementia panel forms…

EPAD Research Participant Panel presented at 28AEC

On 29-31st October, Alzheimer Europe held the 28th Alzheimer Europe Conference “Making dementia a European priority” in Barcelona (Spain). This year, the event gathered more than 800 participants from 46 countries including 35 people with dementia. The programme included 239 oral presentations and 175 poster presentations. We were glad to see our epadista Jose Luis…